Predictors of sentinel lymph node metastasis in Chinese women with clinical T1-T2 N0 breast cancer and a normal axillary ultrasound

被引:2
|
作者
Fu, Fenfen [1 ]
Zhang, Yonghui [1 ]
Sun, Jie [2 ]
Zhang, Chun [1 ]
Zhang, Dongjie [1 ]
Xie, Lingduo [1 ]
Chu, Futao [1 ]
Yu, Xue [1 ]
Xie, Yuntao [1 ,2 ]
机构
[1] Peking Univ, Int Hosp, Dept Breast Surg, Beijing, Peoples R China
[2] Peking Univ Canc Hosp & Inst, Familial & Hereditary Canc Ctr, Beijing 100142, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; sentinel lymph node metastasis; predictors; axillary ultrasonography; LYMPHOVASCULAR INVASION; BIOPSY; DISSECTION; TRIAL; ONCOLOGY; INVOLVEMENT; DISEASE; RISK;
D O I
10.1177/02841851211054191
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background The clinicopathological predictors of sentinel lymph node (SLN) metastasis in clinical T1-T2 N0 (cT1-T2 N0) patients with a normal axillary ultrasound (AUS) are unclear. Purpose To assess the association between clinicopathological characteristics of a primary tumor and SLN metastasis in cT1-T2 N0 patients with a normal AUS. Material and Methods Patients who were diagnosed with cT1-T2 N0 invasive breast cancer and who obtained normal AUS results between October 2016 and September 2018 in a single hospital were included. Clinicopathological data were collected to explore the predictors of SLN metastasis using a multivariate logistic regression model. Results SLN metastasis occurred in 26 patients (18.4%) among 141 AUS-normal patients, of which 24 cases (17.0%) had one or two nodal involvements. In the univariate analysis, tumor location, estrogen receptor (ER) status, progesterone receptor (PR) status, and lymphovascular invasion (LVI) were significantly associated with SLN metastasis (P < 0.05). The multivariate analysis showed that tumor location in the upper outer quadrant (odds ratio [OR] = 4.49, 95% confidence interval [CI] = 1.63-12.37; P = 0.004), positive PR status (OR = 13.35, 95% CI = 1.60-111.39; P = 0.017), and positive LVI (OR = 8.66, 95% CI = 2.20-34.18; P = 0.002) were independent high-risk factors for SLN metastasis. The area under the receiver operating characteristic curve of the regression model was 0.787 (95% CI = 0.694-0.881; P < 0.001). Conclusion Tumor location in the upper outer quadrant, positive PR, and LVI status were found to be significantly high-risk factors for SLN metastasis among cT1-T2 N0 breast cancer patients with a normal AUS result.
引用
收藏
页码:1463 / 1468
页数:6
相关论文
共 50 条
  • [41] Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy
    Jung Whan Chun
    Eunhye Kang
    Hong-Kyu Kim
    Han-Byoel Lee
    Hyeong-Gon Moon
    Jong Won Lee
    Wonshik Han
    [J]. Annals of Surgical Oncology, 2024, 31 : 3168 - 3176
  • [42] Axillary Lymph Node Dissection Versus No Dissection in Patients With T1N0 Breast Cancer
    Agresti, Roberto
    Martelli, Gabriele
    Sandri, Marco
    Tagliabue, Elda
    Carcangiu, Maria Luisa
    Maugeri, Ilaria
    Pellitteri, Cristina
    Ferraris, Cristina
    Capri, Giuseppe
    Moliterni, Angela
    Bianchi, Giulia
    Mariani, Gabriella
    Trecate, Giovanna
    Lozza, Laura
    Langer, Martin
    Rampa, Mario
    Gennaro, Massimiliano
    Greco, Marco
    Menard, Sylvie
    Pierotti, Marco A.
    [J]. CANCER, 2014, 120 (06) : 885 - 893
  • [43] Axillary Recurrence in Breast Cancer Patients with Isolated Tumor Cells in the Sentinel Lymph Node [AJCC N0(i+)]
    Amy C. Degnim
    Shaheen Zakaria
    Judy C. Boughey
    Nicole Sookhan
    Carol Reynolds
    John H. Donohue
    David R. Farley
    Clive S. Grant
    Tanya Hoskin
    [J]. Annals of Surgical Oncology, 2010, 17 : 2685 - 2689
  • [44] Axillary Recurrence in Breast Cancer Patients with Isolated Tumor Cells in the Sentinel Lymph Node [AJCC N0(i+)]
    Degnim, Amy C.
    Zakaria, Shaheen
    Boughey, Judy C.
    Sookhan, Nicole
    Reynolds, Carol
    Donohue, John H.
    Farley, David R.
    Grant, Clive S.
    Hoskin, Tanya
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (10) : 2685 - 2689
  • [45] Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis
    Sonia Martinez Alcaide
    Carlos Alberto Fuster Diana
    Julia Camps Herrero
    Laia Bernet Vegue
    Antonio Valdivia Perez
    Eugenio Sahuquillo Arce
    Juan Blas Ballester Sapiña
    Pedro Juan Gonzalez Noguera
    Jose Marcelo Galbis Caravajal
    [J]. Archives of Gynecology and Obstetrics, 2022, 306 : 2123 - 2131
  • [46] SENTINEL NODE BIOPSY IN T1-T2 ORAL AND OROPHARYNGEAL CANCER REDUCES THE RISK OF OCCULT LYMPH NODE METASTASES
    Flach, G.
    Bloemena, E.
    van Schie, A.
    Hoekstra, O.
    Castelijns, J.
    van der Waal, I.
    Klop, M.
    van Es, R.
    Schepman, K. P.
    van Weert, S.
    Leemans, C. R.
    de Bree, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S42 - S42
  • [47] Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis
    Alcaide, Sonia Martinez
    Diana, Carlos Alberto Fuster
    Herrero, Julia Camps
    Vegue, Laia Bernet
    Perez, Antonio Valdivia
    Arce, Eugenio Sahuquillo
    Sapina, Juan Blas Ballester
    Noguera, Pedro Juan Gonzalez
    Caravajal, Jose Marcelo Galbis
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (06) : 2123 - 2131
  • [48] The prognostic factors of breast cancer related with axillary lymph node metastasis in T1 breast cancer
    Gwak, G.
    Park, K.
    Han, S.
    Kim, K.
    Kim, H.
    Kim, Y.
    Kim, H.
    Kim, K.
    Bae, B.
    Yang, K.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 171 - 172
  • [49] Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1–2 breast cancer
    Na Luo
    Ying Wen
    Qiongyan Zou
    Dengjie Ouyang
    Qitong Chen
    Liyun Zeng
    Hongye He
    Munawar Anwar
    Limeng Qu
    Jingfen Ji
    Wenjun Yi
    [J]. Scientific Reports, 12
  • [50] Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1-2 breast cancer
    Luo, Na
    Wen, Ying
    Zou, Qiongyan
    Ouyang, Dengjie
    Chen, Qitong
    Zeng, Liyun
    He, Hongye
    Anwar, Munawar
    Qu, Limeng
    Ji, Jingfen
    Yi, Wenjun
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)